Development of antineoplastic agents by pharmaceutical companies.
D000903:Antibiotics, Antineoplastic; D000970:Antineoplastic Agents / Q000494:pharmacology / Q000633:toxicity; D001761:Bleomycin / Q000031:analogs & derivatives; D004279:DNA, Viral / Q000494:pharmacology; D004345:Drug Industry; D006027:Glycosides; D009279:Naphthacenes; D013329:Structure-Activity Relationship; D009353:Zinostatin / Q000627:therapeutic use
D000903:Antibiotics, Antineoplastic; D000970:Antineoplastic Agents; D004279:DNA, Viral; D006027:Glycosides; D009279:Naphthacenes; D001761:Bleomycin; D009353:Zinostatin